IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Windlas Biotech Limited is an Pharmaceutical based company, located in Dehradun, Windlas Biotech Limited IPO size was 401.54 Cr. and was issued at 460.00 per share. The share of Windlas Biotech Limited were listed at 406.70 per share and are currently trading at 928.90 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
designing, manufacturing, and selling Energy Storage and Power Conditioning Equipment
Mumbai
Owns and operates storage terminals for liquefied petroleum gas (LPG)
Surat
luxury hospitality company operating under "The Leela" brand in India
New Delhi
Windlas Biotech operates in Pharmaceutical and Domestic Pharmaceutical Formulations Contract Development And Manufacturing. The Issue is listed on BSE,NSE in Aug, 2021. Windlas Biotech IPO size was 401.54 Cr. with Issue price of 460.00 .
Merchant Banker(s) of Windlas Biotech IPO: Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Iifl Securities Limited , SBI Capital Markets Limited
Windlas Biotech IPO subscription was 22.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Windlas Biotech IPO listed at a listing price of 406.70 against the offer price of 460.00.
The current market price of Windlas Biotech is 928.90.
Why Us?
